Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discovery of 5-chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway.
Ioannidis S, Lamb ML, Wang T, Almeida L, Block MH, Davies AM, Peng B, Su M, Zhang HJ, Hoffmann E, Rivard C, Green I, Howard T, Pollard H, Read J, Alimzhanov M, Bebernitz G, Bell K, Ye M, Huszar D, Zinda M. Ioannidis S, et al. Among authors: rivard c. J Med Chem. 2011 Jan 13;54(1):262-76. doi: 10.1021/jm1011319. Epub 2010 Dec 7. J Med Chem. 2011. PMID: 21138246
Discovery of novel Jak2-Stat pathway inhibitors with extended residence time on target.
Guan H, Lamb ML, Peng B, Huang S, Degrace N, Read J, Hussain S, Wu J, Rivard C, Alimzhanov M, Bebernitz G, Bell K, Ye M, Zinda M, Ioannidis S. Guan H, et al. Among authors: rivard c. Bioorg Med Chem Lett. 2013 May 15;23(10):3105-10. doi: 10.1016/j.bmcl.2013.02.111. Epub 2013 Mar 7. Bioorg Med Chem Lett. 2013. PMID: 23562594
Flavor and Device Choices Among People Who Use ENDS: Results From the PATH Study.
Bansal-Travers M, Rivard C, Delnevo CD, Gross A, Anesetti-Rothermel A, Merson B, Xiao H, Cheng YC, Creamer MR, Kimmel HL, Stanton CA, Sharma E, Taylor K, Lauten K, Goniewicz M, Hyland A. Bansal-Travers M, et al. Among authors: rivard c. Am J Prev Med. 2024 Oct 2:S0749-3797(24)00337-4. doi: 10.1016/j.amepre.2024.09.020. Online ahead of print. Am J Prev Med. 2024. PMID: 39362615 Free article.
Changes in the harm perceptions of different types of tobacco products for youth and adults: Waves 1-5 of the population assessment of tobacco and health (PATH) study, 2013-2019.
Bansal-Travers M, Rivard C, Anesetti-Rothermel A, Morse AL, Salim AH, Xiao H, Zandberg I, Creamer MR, Kimmel HL, Sharma E, Taylor K, Hyland A, Fong GT. Bansal-Travers M, et al. Among authors: rivard c. Addict Behav. 2025 Jan;160:108168. doi: 10.1016/j.addbeh.2024.108168. Epub 2024 Sep 20. Addict Behav. 2025. PMID: 39305709 Free article.
Benign Fibroids Mimicking Peritoneal Carcinomatosis.
Dakhlallah S, Rivard C, Boulay AC. Dakhlallah S, et al. Among authors: rivard c. J Obstet Gynaecol Can. 2023 Nov;45(11):101878. doi: 10.1016/j.jogc.2021.12.002. J Obstet Gynaecol Can. 2023. PMID: 37977722 No abstract available.
Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Chaft JE, Oezkan F, Kris MG, Bunn PA, Wistuba II, Kwiatkowski DJ, Owen DH, Tang Y, Johnson BE, Lee JM, Lozanski G, Pietrzak M, Seweryn M, Byun WY, Schulze K, Nicholas A, Johnson A, Grindheim J, Hilz S, Shames DS, Rivard C, Toloza E, Haura EB, McNamee CJ, Patterson GA, Waqar SN, Rusch VW, Carbone DP; LCMC study investigators. Chaft JE, et al. Among authors: rivard c. Nat Med. 2024 Jan;30(1):303. doi: 10.1038/s41591-023-02627-7. Nat Med. 2024. PMID: 37816821 Free PMC article. No abstract available.
335 results